The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer a post-hoc exploratory analysis of the randomized NORDIC9-study

Gabor Liposits

The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer a post-hoc exploratory analysis of the randomized NORDIC9-study

Gabor Liposits

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

12 Downloads (Pure)

Originalsprog	Engelsk
Publikationsdato	1. jul. 2023
Status	Udgivet - 1. jul. 2023
Begivenhed	Wold Congress on Gastrointestinal Cancer 2023: ESMO GI - Barcelona Varighed: 28. jun. 2023 → 1. aug. 2023

Konference

Konference	Wold Congress on Gastrointestinal Cancer 2023
By	Barcelona
Periode	28/06/2023 → 01/08/2023

Dokumenter og links

Open Access versionForlagets udgivne version, 2,45 MBLicens: Ikke-specificeret

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@conference{41fe0d683cd2476a8b52b38e97166606,

title = "The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer a post-hoc exploratory analysis of the randomized NORDIC9-study",

author = "Gabor Liposits",

year = "2023",

month = jul,

day = "1",

language = "English",

note = "Wold Congress on Gastrointestinal Cancer 2023 : ESMO GI, WCGIC 2023 ; Conference date: 28-06-2023 Through 01-08-2023",

}

The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer a post-hoc exploratory analysis of the randomized NORDIC9-study. / Liposits, Gabor.
2023. Poster session præsenteret på Wold Congress on Gastrointestinal Cancer 2023, Barcelona.

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

TY - CONF

T1 - The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer a post-hoc exploratory analysis of the randomized NORDIC9-study

AU - Liposits, Gabor

PY - 2023/7/1

Y1 - 2023/7/1

M3 - Poster

T2 - Wold Congress on Gastrointestinal Cancer 2023

Y2 - 28 June 2023 through 1 August 2023

ER -